Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96ec3985e3ce9b24614fb87bf51a4f12 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2012-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41d9f0727a33c5e2966358417fcf75d2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77af737809ae82c9fc44051fe09f845e |
publicationDate |
2013-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2845318-A1 |
titleOfInvention |
Use of mad2l2 as a stratification marker in the treatment of breast tumours with novel pan-cdk inhibitors |
abstract |
The invention relates to the use of MAD2L2 as a stratification marker in the treatment of breast tumours with novel pan-CDK inhibitors of formula (I). |
priorityDate |
2011-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |